Feeds:
Posts
Comments

Posts Tagged ‘Seroquel’

NEXT WEEK: IIRUSA’s ePharma Summit, Philadelphia, PA. I’ll be there, reporting live via social media. You?

TODAY’S NEWS

AstraZeneca looking down the barrel of 26,000 Seroquel lawsuits. Or so.

New treatment for debilitating hand condition – The Food and Drug Administration Tuesday approved the first drug designed to treat a debilitating hand condition known as Dupuytren’s contracture. The drug, called Xiaflex, is manufactured by Auxilium Pharmaceuticals Inc. of Malvern, Penn., and the company expects to begin selling it by the end of March. An FDA advisory panel in September unanimously recommended approval of the drug…more

A new kind of drug export – BMS employee accused of stealing secrets to try to start own pharma company in India!

Six key areas of learning for pharma and healthcare marketing in 2010.

RECOMMENDED

Outsourcing – Considering outsourcing training technology functions, or meetings/logistics, or even the entire training department? Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations of outsource partners.

PLUS

Want to know the latest about Facebook adoption, and how it impacts business? Read this great post by Jay Baer. And, while we’re talking social networking: what is the goal as it relates to business (my post yesterday on Holistic Common Sense). Plus, Jon Richman on the Seven (soon to be Nine) Uses of Social Media in Business. And, over 1/2 of all adults now go online for health information, while physicians are very heavy users of internet resources (did you know that 1/3 have changed a patient treatment based on an internet search?)

JUST FOR FUN

When engineers get laid off and have too much time on their hands. Sheesh!

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »

TODAY’S NEWS

Celgene to buy Gloucester Pharmaceuticals, another company with a focus on developing drugs for blood cancer. I really like Celgene’s laser-like focus in its product portfolio – very smart.

Keep those new blood thinners coming.

AstraZeneca‘s Seroquel gets an expanded label for Major Depressive Disorder (add-on treatment).

Folotyn: 30K/month cancer treatment?? Wow (from NY Times).

The race for the new oral MS drug approval – did Novartis just take the lead?

RECOMMENDED

Medical Device Training. The Impactiviti network of providers has what you need.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

Pharma: Socializing in a Straitjacket? A somewhat shallow brushstroke in AdWeek about pharma and social media. AND – only TWO FDA inspectors in all of China (where much drug manufacturing is moving)? I bet that gets changed fast!

JUST FOR FUN

Will a young dog remember a family member who has been gone for 3 months? Watch and see!

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »